1 follower
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
Aetna Wun Trombley
Gameto
4 followers
Synthekine
3 followers
Tango Therapeutics
2 followers
Caribou Biosciences
2 followers
Vera Therapeutics
2 followers
Neogene Therapeutics
2 followers
Kyverna Therapeutics
7 followers
Day One Biopharmaceuticals
1 follower
Apogee Therapeutics
1 follower
Cargo
1 follower
Aura Biosciences
1 follower
Explore companies